Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arena Pharmaceuticals (NQ: ARNA ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 10, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Arena Pharmaceuticals < Previous 1 2 3 4 Next > Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 18, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Cannabis Stock Gainers And Losers From June 17, 2021 June 17, 2021 GAINERS: Invictus MD Strategies (OT... Via Benzinga Topics Cannabis Exposures Cannabis Steven Schoch Elected to Arena Pharmaceuticals Board of Directors June 14, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Earnings Scheduled For May 5, 2021 May 05, 2021 Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Cannabis Stock Gainers And Losers From June 10, 2021 June 10, 2021 GAINERS: Cipher Pharms Inc (OTC: Via Benzinga Topics Cannabis Exposures Cannabis Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE) June 09, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO) June 08, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels June 08, 2021 Via FinancialNewsMedia Topics Cannabis Economy Exposures COVID-19 Cannabis Economy Arena Pharmaceuticals Earns "A" Rating from MSCI ESG, a Leading Rating Agency for Sustainable Investments June 03, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 19, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021 May 18, 2021 Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,... Via Benzinga Arena Pharmaceuticals Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments May 12, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Arena Pharmaceuticals Inc (ARNA) Q1 2021 Earnings Call Transcript May 06, 2021 ARNA earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Arena Reports First Quarter Financial Results with Strong Cash Position and Continued Progress on Pipeline Over the Quarter May 05, 2021 From ARENA Pharmaceuticals Via Business Wire The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Arena Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Corporate Update on May 5 April 28, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2021 April 27, 2021 Upgrades According to JP Morgan, the prior rating for BP Midstream Partners LP (NYSE:BPMP) was changed from Neutral to Overweight. For the fourth quarter, BP Midstream... Via Benzinga Arena Pharmaceuticals Presents Clinician and Patient Reported Outcomes Data from Phase 2b ADVISE Trial Evaluating Etrasimod in Adult Atopic Dermatitis During a Late-Breaking Session at American Academy of Dermatology VMX April 23, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report April 19, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs April 23, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... Via Benzinga Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial During Late-Breaking Research Session at American Academy of Dermatology Virtual Meeting Experience April 19, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 16, 2021 From Arena Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
